1. InMode promotes Michael Dennison to President of North America. 2. Dennison has extensive sales experience in medical devices. 3. His leadership is expected to drive growth and market expansion. 4. InMode aims to enhance value for partners and set industry standards.
Michael Dennison's appointment could lead to strategic growth and improved revenue. Historically, effective leadership transitions correlate with positive stock performance.
The article outlines a significant leadership change that may influence company direction and revenue. New leadership often revitalizes investor confidence.
Stock performance may improve as market responds to leadership changes. Similar past transitions in other companies have shown immediate positive reactions.
IRVINE, Calif., Nov. 3, 2025 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD), a leading global provider of innovative medical technologies, has appointed Michael Dennison, most recently Vice President of Sales, as President of North America.
Dennison has held nearly every sales position in the aesthetic medical device industry, consistently producing at the highest level in each. With close to a decade of leadership experience at InMode, Dennison has advanced through roles from District Sales Manager to Vice President of Sales, driving national revenue growth, expanding market share, and strengthening the company's distribution network across North America.
"This promotion marks an exciting new chapter for InMode, led by a visionary leader with a proven commitment to cultivating talent and driving market excellence," said Moshe Mizrahy, CEO of InMode. "Dennison's extensive industry experience and inspirational leadership will be pivotal in advancing our strategic initiatives and accelerating growth, as part of our North American restructuring."
"I am honored to continue building on InMode's strong foundation," said Dennison. "Together, we will accelerate momentum in the North American market, deliver greater value to our partners, and set new standards of excellence across the aesthetic and medical device industry."
Before joining InMode, Dennison held multiple leadership positions at Cynosure, where he consistently exceeded sales targets and built high-performing teams that drove significant revenue growth.
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.
Press Contact:
Behrman Cesa Communications
inmode@behrmancesa.com
Investor Contact:
MS-IR LLC
Miri Segal – Scharia
ir@inmodemd.com
Photo - https://mma.prnewswire.com/media/2800683/Michael_Dennison.jpg
Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/inmode-appoints-michael-dennison-as-president-of-north-america-302601451.html
SOURCE InMode Ltd.